Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending March 31, 2022 was 40.2% (a -957.14% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth increased by 479.25%
- Annual Research and Development (R&D) Expenses Growth for 2021 was 17.77% (a -41.26% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 30.25% (a -37.55% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2019 was 48.44% (a 141.48% increase from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending March 31, 2022 was 22.33% (a 25.66% increase compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth increased by 25.87% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 31 Mar '22 | 31 Dec '21 | 30 Sep '21 | 30 Jun '21 |
|---|---|---|---|
| 22.33% | 17.77% | 32.04% | 17.74% |
Visit stockrow.com/MBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Mustang Bio, Inc.
Most recent Research and Development (R&D) Expenses Growthof MBIO including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Mustang Bio, Inc.
Mustang Bio, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 40.2% | – | – | – | – |
| 2021 | -4.69% | 77.82% | 6.94% | 21.48% | 17.77% |
| 2020 | 32.15% | 3.31% | 58.48% | 29.07% | 30.25% |
| 2019 | 35.69% | 26.8% | 97.44% | 69.68% | 48.44% |
| 2018 | -18.94% | 153.86% | -10.94% | 240.91% | 20.06% |
| 2017 | 84.7% | 337.26% | 586.25% | 125.93% | 138.4% |
| 2016 | 1098.07% | -77.13% | -85.43% | -55.74% | 0.0% |
| 2015 | -91.65% | – | – | – | -100.0% |
Business Profile of Mustang Bio, Inc.
Sector: Healthcare
Industry: Biotechnology